NUCYNTA

This brand name is authorized in United States. It is also authorized in Canada, Singapore.

Active ingredients

The drug NUCYNTA contains one active pharmaceutical ingredient (API):

1	Tapentadol UNII 71204KII53 - TAPENTADOL HYDROCHLORIDE
	Tapentadol is a strong analgesic with µ-agonistic opioid and additional noradrenaline reuptake inhibition properties. Tapentadol exerts its analgesic effects directly without a pharmacologically active metabolite.
	Read more about Tapentadol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NUCYNTA ER Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AX06		N Nervous system → N02 Analgesics → N02A Opioids → N02AX Other opioids
Discover more medicines within N02AX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02378272, 02378280, 02378299, 02415577, 02415585, 02415593, 02415607, 02415615
SG	Health Sciences Authority	14607P, 14608P, 14609P, 14610P, 14611P
US	FDA, National Drug Code	24510-050, 24510-058, 24510-075, 24510-100, 24510-116, 24510-174, 24510-232, 24510-291, 55700-555, 55700-565, 55700-792, 55700-796, 55700-797, 69865-210, 69865-220, 69865-230, 69865-240, 69865-245, 69865-250, 69865-260, 69865-265